Agilent Technologies, Inc.

Form 483 issued July 6, 2015 · Santa Clara, California

Inspection
Jun 2 – Jul 6, 2015
Investigator
Mark E. Chan
Observations
2
Pages
3
FEI number
2916205

In short: On July 6, 2015, FDA issued a Form 483 with 2 observations to Agilent Technologies, Inc. in Santa Clara, California (FEI 2916205) after an inspection that ran Jun 2 – Jul 6, 2015. The investigator was Mark E. Chan. Most observations concern cAPA and production & process controls; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

CAPA and production & process controls account for 2 of 2 observations.

CAPA1
Production & process controls1

Most cited: 21 CFR 820.198(a) (1×) · 820.120 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

  2. 02

    Procedures to control labeling activities have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Agilent Technologies, Inc.?

FDA listed 2 observations on this Form 483, mostly about cAPA and production & process controls. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected Agilent Technologies, Inc.?

Mark E. Chan is named on this Form 483, for the inspection of Jun 2 – Jul 6, 2015. Each investigator has a profile showing what they cite most.

When was Agilent Technologies, Inc. inspected by FDA?

The inspection ran Jun 2 – Jul 6, 2015, and the Form 483 is dated July 6, 2015.

How do I get the full Form 483 for Agilent Technologies, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free